Arthritic Psoriasis: Clinical Trials

2 trials for Arthritic Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Arthritic Psoriasis: new trials by email Literature Review of Arthritic Psoriasis trials Research Report on Arthritic Psoriasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
BMS-986165 Capsule, BMS-986165 Tablet - Systemic Lupus Erythematosus, Arthritic Psoriasis
Phase 1CompletedBristol-Myers Squibb492017-09-132020-02-25
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
BMS-986165, Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) - Systemic Lupus Erythematosus, Arthritic Psoriasis
Phase 1CompletedBristol-Myers Squibb492017-09-012020-03-19

Narrower conditions

Arthritis, Psoriatic (2)  ·  Inflammatory Bowel Diseases (2)  ·  Lupus Erythematosus, Systemic (2)  ·  Psoriasis (2)

Broader conditions

Arthritis (2)  ·  Autoimmune Diseases (2)  ·  Bone Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Immune System Diseases (2)  ·  Intestinal Diseases (2)  ·  Joint Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Papulosquamous (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Spinal Diseases (2)

Interventions

deucravacitinib (2)

Sponsors

Bristol-Myers Squibb (2)

Countries

United States (2)